WELLINGTON MANAGEMENT GROUP LLP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 18 filers reported holding CARDLYTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$1,498,892
+4.2%
2,453,000
-5.0%
0.00%
Q2 2023$1,438,071
+111.4%
2,583,000
+58.7%
0.00%
Q1 2023$680,415
+1.4%
1,628,000
+3.2%
0.00%
Q4 2022$671,351
+92.9%
1,578,000
+166.1%
0.00%
Q3 2022$348,000
-21.8%
593,0000.0%0.00%
Q2 2022$445,000
-6.9%
593,000
+25.4%
0.00%
Q1 2022$478,000
-12.5%
473,000
-4.1%
0.00%
Q4 2021$546,000
-10.6%
493,000
+1.0%
0.00%
Q3 2021$611,000488,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$5,149,0001.88%
LINDEN ADVISORS LP 65,612,000$66,940,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 38,478,000$39,110,0000.38%
Teton Advisors, Inc. 1,030,000$1,061,0000.18%
683 Capital Management, LLC 2,000,000$2,040,0000.11%
Nicholas Investment Partners, LP 1,385,000$1,401,0000.10%
GABELLI FUNDS LLC 6,920,000$7,128,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 10,000,000$10,165,0000.03%
Citadel Advisors 98,500,000$100,325,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$309,0000.00%
View complete list of CARDLYTICS INC shareholders